1. Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profiling
- Author
-
Zayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, Yong Chan Kim, Sook Jin Kwon, Kyoung-Ho Song, Eu Suk Kim, Young Goo Song, Yoon Soo Park, Jin Young Ahn, Jun Yong Choi, Won Suk Choi, Seongman Bae, Sung-Han Kim, Shin-Woo Kim, Ki Tae Kwon, Hye Won Jeong, Kyong Ran Peck, Eun-Suk Kang, June-Young Koh, Jae-Hoon Ko, and Tae Hyun Yoon
- Subjects
Aging ,COVID-19 vaccines ,Mass cytometry ,Immunity ,Immunologic diseases. Allergy ,RC581-607 ,Geriatrics ,RC952-954.6 - Abstract
Abstract Background Age-dependent immune responses to coronavirus disease 2019 (COVID-19) vaccinations and breakthrough infections (BIs) in young and middle-aged individuals are unclear. Methods This nationwide multicenter prospective cohort study analyzed immune responses in participants of the ChAdOx1 (ChAd)-ChAd-mRNA vaccine group using cytometry by time-of-flight, anti-spike protein antibody (Sab) and anti-nucleocapsid antibody (Nab) titers, plaque reduction neutralization tests (PRNTs), and interferon-gamma (IFN-γ) release assays at various time points. Results We evaluated 347 participants with an average age of 38.9 ± 9.4 years (range: 21–63). There was a significant inverse correlation between age and Sab levels after the second dose (slope − 14.96, P = 0.032), and this was more pronounced after the third dose (slope − 208.9, P
- Published
- 2024
- Full Text
- View/download PDF